Court Rules AstraZeneca Not Immune From Liability in COVID Vaccine Injury Case
Landmark Decision Challenges Legal Protections for Vaccine Makers
A U.S. federal court has ruled that AstraZeneca is not protected by the Public Readiness and Emergency Preparedness Act (PREP Act) in a lawsuit filed by Brianne Dressen, a woman injured during a clinical trial for the company’s COVID-19 vaccine. The court’s decision rejects AstraZeneca’s claim of immunity, allowing Dressen’s breach-of-contract lawsuit to proceed.
Dressen, co-founder of the nonprofit React19 which advocates on behalf of vax injury victims, alleges that AstraZeneca’s vaccine caused her severe health issues and that the company failed to honour its promise to provide medical treatment for injuries sustained during the trial. While the PREP Act shields manufacturers from many legal claims related to COVID-19 vaccines, the court ruled that breach-of-contract claims are not covered under the law.
This ruling could have significant implications, potentially opening the door for more lawsuits challenging the legal protections for vaccine makers. Legal experts suggest it may set a precedent for future claims related to fraud, false advertising and other legal exceptions.
To read the full article by The Defender‘s Michael Nevradakis, Ph.D. and learn more about the potential impact of this ruling, click HERE.
*************************************************************************************************************